Clinical implications of PTEN loss in prostate cancer (2018)
- Authors:
- Autor USP: SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- DOI: 10.1038/nrurol.2018.9
- Subjects: PRÓSTATA; NEOPLASIAS; BIOMARCADORES; GENÉTICA MÉDICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Nature Reviews Urology
- ISSN: 1759-4812
- Volume/Número/Paginação/Ano: v. 15, n. 4, p. 222–234, 2018
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
JAMASPISHVILI, Tamara et al. Clinical implications of PTEN loss in prostate cancer. Nature Reviews Urology, v. 15, n. 4, p. 222–234, 2018Tradução . . Disponível em: https://doi.org/10.1038/nrurol.2018.9. Acesso em: 19 abr. 2024. -
APA
Jamaspishvili, T., Berman, D. M., Ross, A. E., Scher, H. I., Marzo, A. M. D., Squire, J. A., & Lotan, T. L. (2018). Clinical implications of PTEN loss in prostate cancer. Nature Reviews Urology, 15( 4), 222–234. doi:10.1038/nrurol.2018.9 -
NLM
Jamaspishvili T, Berman DM, Ross AE, Scher HI, Marzo AMD, Squire JA, Lotan TL. Clinical implications of PTEN loss in prostate cancer [Internet]. Nature Reviews Urology. 2018 ; 15( 4): 222–234.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1038/nrurol.2018.9 -
Vancouver
Jamaspishvili T, Berman DM, Ross AE, Scher HI, Marzo AMD, Squire JA, Lotan TL. Clinical implications of PTEN loss in prostate cancer [Internet]. Nature Reviews Urology. 2018 ; 15( 4): 222–234.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1038/nrurol.2018.9 - Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
- STAT1-associated intratumoural TH1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer
Informações sobre o DOI: 10.1038/nrurol.2018.9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
